88°F
weather icon Clear

Why Medicare shopping season could bring a dose of confusion

Thinner benefits and coverage changes await many older Americans shopping for health insurance this fall. That’s if their plan is even still available in 2025.

More than a million people will probably have to find new coverage as major insurers cut costs and pull back from markets for Medicare Advantage plans, the privately run version of the federal government’s coverage program mostly for people 65 and older.

Industry experts also predict some price increases for Medicare prescription drug plans as required coverage improvements kick in.

Voters will learn about the insurance changes just weeks before they pick the next president and as Democrat Kamala Harris campaigns on promises to lower health care costs.

“This could be bad news for Vice President Harris. If that premium is going up, that’s a very obvious sign that you’re paying more,” said Massey Whorley, an analyst for health care consulting company Avalere. “That has significant implications for how they’re viewing the performance of the current administration.”

Insurance agents say the distraction of the election adds another complication to an already challenging annual enrollment window that starts this month.

Insurers pulling back

Medicare Advantage plans will cover more than 35 million people next year, or around half of all people enrolled in Medicare, according to the federal government. Insurance agents say they expect more people than usual will have to find new coverage for 2025 because their insurer has either ended a plan or left their market.

The health insurer Humana expects more than half a million customers — about 10 percent of its total — to be affected as it pulls Medicare Advantage plans from places around the country. Many customers will be able to transfer to other Humana plans, but company leaders still anticipate losing a few hundred thousand customers.

CVS Health’s Aetna projects a similar loss, and other big insurers have said they are leaving several states.

Insurers say rising costs and care use, with reimbursement cuts from the government, are forcing them to pull back.

Tougher search for some

When insurers leave Medicare Advantage markets, they tend to stop selling plans that have lower quality ratings and those with a higher proportion of Black buyers, said Dr. Amal Trivedi, a Brown University public health researcher.

He noted that market exits can be particularly hard on people with several doctors and on patients with cognitive trouble such as dementia.

Most markets will still have dozens of plan choices. But finding a new option involves understanding out-of-pocket costs for each choice, plus figuring out how physicians and regular prescriptions are covered.

“People don’t like change when it comes to health insurance because you don’t know what’s on the other side of the fence,” said Tricia Neuman, a Medicare expert at KFF, a nonprofit that researches health care.

Plans that don’t leave markets may raise deductibles and trim perks such as cards used to pay for utilities or food.

Those proved popular in recent years as inflation rose, said Danielle Roberts, co-founder of the Fort Worth, Texas, insurance agency Boomer Benefits.

“It’s really difficult for a person on a fixed income to choose a health plan for the right reasons … when $900 on a flex card in free groceries sounds pretty good,” she said.

Don’t ‘sleep’ on choice

Prices also could rise for some stand-alone Part D prescription drug plans, which people pair with traditional Medicare coverage. KFF says that population includes more than 13 million people.

The Centers for Medicare and Medicaid Services said that premiums for these plans will decrease about 4 percent on average to $40 next year.

But brokers and agents say premiums can vary widely, and they still expect increases. They also expect fewer plan choices and changes to formularies, or lists of covered drugs. Roberts said she has already seen premium hikes of $30 or more from some plans for next year.

Any price shift will hit a customer base known to switch plans for premium changes as small as $1, said Fran Soistman, CEO of the online insurance marketplace eHealth.

The changes come as a congressional-approved coverage overhaul takes hold. Most notably, out-of-pocket drug costs will be capped at $2,000 for those on Medicare, an effort championed by Democrats and President Joe Biden in 2022.

In the long run, these changes will lead to a “much richer benefit,” Whorley said.

KFF’s Neuman noted that the cap on drug costs will be especially helpful to cancer patients and others with expensive prescriptions. She estimates about 1.5 million people will benefit.

To ward off big premium spikes because of the changes, the Biden administration will pull billions of dollars from the Medicare trust fund to pay insurers to keep premium prices down, a move some Republicans have criticized. Insurers will not be allowed to raise premium prices beyond $35 next year.

People will be able to sign up for 2025 coverage between Oct. 15 and Dec. 7. Experts say all the potential changes make it important for shoppers to study closely any new choices or coverage they expect to renew.

“This is not a year to sleep on it and just re-enroll in the status quo,” said Whorley, the health care analyst.

THE LATEST
Power plants: Prime protein sources to cut back on meat

Many people consider eating less meat. But they sometimes hesitate because they are concerned about how they would replace all that lost protein.

Therapist inspires own daughters to follow his career path

Arguably the most talented therapist I know, Las Vegan Jimmy Monaghan has lived a life that could well inspire a smash-hit Netflix documentary.

What does a diagnosis of dense breasts mean?

“About 50 percent of women have dense breast tissue,” says Dr. Kristin Robinson, a Mayo Clinic breast radiologist.

Should people 65 and older get the pneumonia vaccine?

Each year, pneumonia leads a whopping 1.5 million people to visit medical emergency departments in the U.S. and causes roughly 50,000 deaths.